🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Treatment Gaining Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Viewers are urged to message these accounts directly for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and assertions of next-day UK delivery. Sellers promote the drug there before directing buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting substances of uncertain source.

Some experts stated the popularity for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for human use under the British medical regulations.

Some influencers try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach medicines, advertising, and customer regulations, risking penalties, prosecution or imprisonment.

Platform Reaction and Material Elimination

Based on TikTok, the service has removed problematic material and prohibited associated keywords and query recommendations. The organization said it was committed to keeping the platform secure and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Research also found communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, populated with images of slimming results, positive reviews and step-by-step instructions for preparing or administering at residence.

After moments of joining one group, a seller shared WhatsApp details, where the majority of transactions take place. The vendor provided an guidebook and promised delivery within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about body mass, health issues or past usage.

Item Information and Costs

Inside these groups, posts display black plastic packages with postal service stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When questioned how much time a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service said it regularly moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they can’t verify. Even if the research behind this drug is sound, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs rising, individuals are using social media. But fake treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has previously encountered patients injured by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to possibly serious medical dangers”.